JNCI_Now's profile picture. Journal of the National Cancer Institute (JNCI) & JNCI Cancer Spectrum publish peer-reviewed #research on #cancer and #oncology. @OUPAcademic journals.

JNCI

@JNCI_Now

Journal of the National Cancer Institute (JNCI) & JNCI Cancer Spectrum publish peer-reviewed #research on #cancer and #oncology. @OUPAcademic journals.

Pinned

📢 Calling Early Career Investigators! Is publishing your research with a respected journal on your 2024 #Resolutions list? You're in luck - @JNCI_Now is creating a special section devoted to publishing manuscripts from ECIs. Find out more here: academic.oup.com/jnci/pages/ear…

JNCI_Now's tweet image. 📢 Calling Early Career Investigators!

Is publishing your research with a respected journal on your 2024 #Resolutions list? 

You're in luck - @JNCI_Now is creating a special section devoted to publishing manuscripts from ECIs. 

Find out more here: academic.oup.com/jnci/pages/ear…

Some counties are subject to worsening racial disparities in PCSM w/local drivers changing over time. Identifying locations of highest/lowest mortality disparities remains critical to finding solutions: oxford.ly/3YOqJ72 @SamWashUro @dr_coops @mleapman @UCSFUrology


Preterm birth mediates the association between chemotherapy exposure in utero and adverse neonatal outcomes. @AmyMetcalfePhD oxford.ly/3EQCd3d


.@realjdownie et al. reveal sex-specific metabolite associations w/ #ColorectalCancer risk in LT prospective #metabolomics study of men+women, adding new insights into CRC etiopathogenesis + risk prediction. @HarvardChanSPH @AndyChanMD @MGH_CTEU @DADrewPhD oxford.ly/3GTOULi


ORR, PFS and OS similar among those with dMMR vs pMMR EC treated w/ 1L platinum-doublet chemo in RCTs. Chemo+IO important for both subgroups until results of trials IO vs chemo+IO available. @angelinatjokdoc @lindamileshkin @peeysei oxford.ly/4m8si9H


Systematic review reveals positive associations between anxiety, depression and biological/functional aging among cancer survivors. More on this + next steps: oxford.ly/4iZiFYm @brendoesscience @rachellebrick @thenci @BrenDoesScience @RachelleBrick

JNCI_Now's tweet image. Systematic review reveals positive associations between anxiety, depression and biological/functional aging among cancer survivors. More on this + next steps: oxford.ly/4iZiFYm
@brendoesscience @rachellebrick @thenci @BrenDoesScience @RachelleBrick

POLAR - a genomic classifier which predicts RT benefit in breast radiotherapy. A meta-analysis of three randomized trials for validation of this assay is presented in the JNCI. @per_krep150 oxford.ly/4m2pPh9


Running a randomised controlled cancer screening trial to evaluate a blood-based screening test? @petersasieni and evaluate sample size requirements for two innovative designs where the control arm are retrospectively tested. @QMUL_WIPH oxford.ly/4iUun6D


Mammalian models of cancer research have transformed cancer research. This commentary reports on the use of precision cancer models across a diversity of scales and how best to implement models for advancing cancer treatment. @Dukesurgery, @DukeCancer oxford.ly/4lWqFfi


A IDATA study show that physical activity is linked to a range of metabolites, many associated with breast cancer prevention. These results suggest exercise may protect against cancer via specific metabolic pathways. oxford.ly/4d9nUTV


Despite excellent prognosis, the majority of annual breast cancer deaths are due to metastatic recurrences of stage I/II cancers. Strategies are needed to further reduce death from stage I/II cancers. oxford.ly/44V3kVd


The GG1-CANCER? symposium gathered a multidisciplinary panel of international luminaries to ask the question from many different critical angles: "When is prostate cancer really cancer?" @dr_coops oxford.ly/4jumndk


Prognostic factors for sigmoid colon cancer with liver metastasis identified via SEER database. Nomograms for cause-specific and overall survival and show strong performance. New web app aids in survival risk stratification: oxford.ly/42AjzWj #CRC


Performing outreach and engagement is an important step towards helping cancer centers reduce the cancer burden in their catchment areas. How to best track and evaluate these efforts, however, remains an unanswered question. oxford.ly/42y5A3b


COVID-19 pandemic led to declines in cancer rates in 2020 due to screening disruptions. A study using 2021 SEER data found that while overall rates were close to pre-pandemic levels, they didn't account for delayed 2020 diagnoses. oxford.ly/42zXdEr


Despite excellent prognosis, the majority of annual breast cancer deaths are due to metastatic recurrences of stage I/II cancers. Strategies are needed to further reduce death from stage I/II cancers. @YaleCancer oxford.ly/4jWJ0Y2


The GG1-CANCER? symposium gathered a multidisciplinary panel of international luminaries to ask the question from many different critical angles: "When is prostate cancer really cancer?" @dr_coops oxford.ly/3EGB65T


Men with prostate cancer had substantially increased risk of anxiety disorders. Men with prostate cancer need close monitoring for timely detection and treatment of anxiety, particularly shortly after prostate cancer diagnosis. @UTHealthHouston oxford.ly/4lMrXJG


An #AI radiomics-based tool for #pulmonarynodule risk stratification provides clinical utility in real-world patients undergoing bronchoscopic lung biopsy. @RogerKimMD, @AnilVachani, @PC3Innovation, @PennCancer, @PennPulmonary


Study found well-controlled glycemia in lung cancer patients also having a diagnosis of diabetes statistically significantly improved overall survival across diverse populations. This finding has implications for the management of lung cancer. #LungCancer oxford.ly/3Yfkclw


Loading...

Something went wrong.


Something went wrong.